Listed

Sanofi

An insider at 4 companies in coverage, as reported on Form 4. SEC CIK 1121404. Latest Form 4 filed Jun 6, 2017.

Share

Share this page

Story card, 1080 × 1920

Roles

As stated on the filings: the relationship to the company and any officer title.

CompanyRoleTransactionsFirstLatest
Latigo Biotherapeutics, Inc.LTGO10% owner42026-08-102026-08-10
Regeneron Pharmaceuticals, Inc.REGN10% owner5512010-10-132020-06-09
Fulcrum Therapeutics, Inc.FULC10% owner32019-07-222019-07-22
Alnylam Pharmaceuticals, Inc.ALNY10% owner62015-01-222017-05-31

Transactions: 564

Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.

What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.

DateCompanyTransactionSharesReported priceValueFiling
2017-06-02Regeneron Pharmaceuticals, Inc.10% owner Purchase12,020$475.1593$5.7mForm 4
2017-06-02Regeneron Pharmaceuticals, Inc.10% owner Purchase7,068$473.8843$3.3mForm 4
2017-06-02Regeneron Pharmaceuticals, Inc.10% owner Purchase5,806$473.0711$2.7mForm 4
2017-06-02Regeneron Pharmaceuticals, Inc.10% owner Purchase7,443$471.8245$3.5mForm 4
2017-06-02Regeneron Pharmaceuticals, Inc.10% owner Purchase13,544$470.7248$6.4mForm 4
2017-06-02Regeneron Pharmaceuticals, Inc.10% owner Purchase2,132$469.8097$1.0mForm 4
2017-06-02Regeneron Pharmaceuticals, Inc.10% owner Purchase400$468.10$187.2kForm 4
2017-06-02Regeneron Pharmaceuticals, Inc.10% owner Purchase402$466.3828$187.5kForm 4
2017-05-31Alnylam Pharmaceuticals, Inc.10% owner Purchase297,501$71.87$21.4mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase2,110$379.5636$800.9kForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase9,520$378.7635$3.6mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase5,313$377.8368$2.0mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase3,851$376.7488$1.5mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase3,016$375.8789$1.1mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase3,830$374.5922$1.4mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase2,784$373.9018$1.0mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase2,675$372.8741$997.4kForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase1,259$371.5346$467.8kForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase900$370.1789$333.2kForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase2,517$369.30$929.5kForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase2,336$368.3472$860.5kForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase1,986$367.2911$729.4kForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase3,979$366.0528$1.5mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase19,858$365.2018$7.3mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase13,226$364.3224$4.8mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase6,546$363.3534$2.4mForm 4
2017-01-11Regeneron Pharmaceuticals, Inc.10% owner Purchase1,592$362.4664$577.0kForm 4
2016-06-14Regeneron Pharmaceuticals, Inc.10% owner Purchase1,007$367.0462$369.6kForm 4
2016-06-14Regeneron Pharmaceuticals, Inc.10% owner Purchase9,893$366.3964$3.6mForm 4
2016-06-14Regeneron Pharmaceuticals, Inc.10% owner Purchase16,935$365.2133$6.2mForm 4
2016-06-14Regeneron Pharmaceuticals, Inc.10% owner Purchase5,836$364.0373$2.1mForm 4
2016-06-14Regeneron Pharmaceuticals, Inc.10% owner Purchase4,745$363.2826$1.7mForm 4
2016-06-14Regeneron Pharmaceuticals, Inc.10% owner Purchase19,708$362.1509$7.1mForm 4
2016-06-14Regeneron Pharmaceuticals, Inc.10% owner Purchase6,607$361.4392$2.4mForm 4
2016-02-17Regeneron Pharmaceuticals, Inc.10% owner Purchase300$398.38$119.5kForm 4
2016-02-17Regeneron Pharmaceuticals, Inc.10% owner Purchase3,400$397.0707$1.4mForm 4
2016-02-17Regeneron Pharmaceuticals, Inc.10% owner Purchase11,018$396.2026$4.4mForm 4
2016-02-17Regeneron Pharmaceuticals, Inc.10% owner Purchase13,288$395.3203$5.3mForm 4
2016-02-17Regeneron Pharmaceuticals, Inc.10% owner Purchase12,988$394.2403$5.1mForm 4
2016-02-17Regeneron Pharmaceuticals, Inc.10% owner Purchase6,730$393.1577$2.6mForm 4
2016-02-17Regeneron Pharmaceuticals, Inc.10% owner Purchase27,088$391.8482$10.6mForm 4
2016-02-17Regeneron Pharmaceuticals, Inc.10% owner Purchase3,681$391.2307$1.4mForm 4
2016-02-17Regeneron Pharmaceuticals, Inc.10% owner Purchase1,507$390.1449$587.9kForm 4
2016-02-16Regeneron Pharmaceuticals, Inc.10% owner Purchase600$393.95$236.4kForm 4
2016-02-16Regeneron Pharmaceuticals, Inc.10% owner Purchase7,301$393.2723$2.9mForm 4
2016-02-16Regeneron Pharmaceuticals, Inc.10% owner Purchase14,692$392.3656$5.8mForm 4
2016-02-16Regeneron Pharmaceuticals, Inc.10% owner Purchase33,131$391.3591$13.0mForm 4
2016-02-16Regeneron Pharmaceuticals, Inc.10% owner Purchase14,303$390.4695$5.6mForm 4
2016-02-16Regeneron Pharmaceuticals, Inc.10% owner Purchase6,789$389.4759$2.6mForm 4
2016-02-16Regeneron Pharmaceuticals, Inc.10% owner Purchase2,196$388.2999$852.7kForm 4

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 19:35 ET. Listed shows no prices and gives no investment advice.